Medifast
MED
#9452
Rank
A$0.19 B
Marketcap
A$17.75
Share price
3.14%
Change (1 day)
-8.50%
Change (1 year)

Earnings for Medifast (MED)

Earnings in 2026 (TTM): -A$28.85 Million

According to Medifast's latest financial reports the company's current earnings are A$0.31 Billion. In 2025 the company made an earning of -A$20.2 Million a decrease over its 2024 earnings that were of A$4.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Medifast from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$28.85 Million42.84%
2025 -A$20.2 Million-593.64%
2024 A$4.09 M-97.72%
2023 A$0.17 B-31.61%
2022 A$0.26 B-14.56%
2021 A$0.30 B61.25%
2020 A$0.19 B47.36%
2019 A$0.12 B31.82%
2018 A$98.12 M74.26%
2017 A$56.3 M47.56%
2016 A$38.16 M-6.36%
2015 A$40.75 M-16.28%
2014 A$48.67 M2%
2013 A$47.72 M44.4%
2012 A$33.05 M-16.75%
2011 A$39.7 M-12.14%
2010 A$45.18 M63.85%
2009 A$27.57 M136.71%
2008 A$11.65 M35.74%
2007 A$8.58 M-142.56%
2006 -A$20.17 Million-448.43%
2005 A$5.78 M35.62%
2004 A$4.26 M-16.51%
2003 A$5.11 M
2000 A$0.68 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.12 Billion 309.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
-A$0.12 Billion 301.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bellerophon Therapeutics
BLPH
-A$15.68 Million-43.43%๐Ÿ‡บ๐Ÿ‡ธ USA